PMC:7306567 / 2109-2670 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T3","span":{"begin":355,"end":365},"obj":"Body_part"},{"id":"T4","span":{"begin":381,"end":385},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma62860"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"LitCovid-PubTator","denotations":[{"id":"35","span":{"begin":39,"end":62},"obj":"Disease"},{"id":"36","span":{"begin":150,"end":158},"obj":"Disease"},{"id":"37","span":{"begin":170,"end":193},"obj":"Disease"},{"id":"47","span":{"begin":209,"end":241},"obj":"Disease"},{"id":"48","span":{"begin":322,"end":343},"obj":"Disease"},{"id":"49","span":{"begin":355,"end":393},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"MESH:D055732"},{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"MESH:C000657245"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:D055732"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D055744"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"MESH:D009503"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:C563515"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":18,"end":27},"obj":"Disease"},{"id":"T18","span":{"begin":49,"end":62},"obj":"Disease"},{"id":"T19","span":{"begin":150,"end":158},"obj":"Disease"},{"id":"T20","span":{"begin":180,"end":193},"obj":"Disease"},{"id":"T21","span":{"begin":228,"end":241},"obj":"Disease"},{"id":"T22","span":{"begin":332,"end":343},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0001475"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T15","span":{"begin":251,"end":252},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T16","span":{"begin":379,"end":385},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T4","span":{"begin":243,"end":246},"obj":"Chemical"}],"attributes":[{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A5","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":209,"end":241},"obj":"Phenotype"},{"id":"T7","span":{"begin":243,"end":246},"obj":"Phenotype"},{"id":"T8","span":{"begin":332,"end":343},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0020103"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0001875"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"LitCovid-sentences","denotations":[{"id":"T19","span":{"begin":196,"end":208},"obj":"Sentence"},{"id":"T20","span":{"begin":209,"end":514},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T26","span":{"begin":39,"end":48},"obj":"UBERON:0002048"},{"id":"T27","span":{"begin":150,"end":158},"obj":"SP_7"},{"id":"T28","span":{"begin":170,"end":179},"obj":"UBERON:0002048"},{"id":"T29","span":{"begin":218,"end":227},"obj":"UBERON:0002048"},{"id":"T30","span":{"begin":305,"end":316},"obj":"NCBITaxon:1"},{"id":"T31","span":{"begin":355,"end":365},"obj":"CL:0000775"},{"id":"T32","span":{"begin":379,"end":385},"obj":"CL:0000084"},{"id":"T33","span":{"begin":484,"end":501},"obj":"CHEBI:35705;CHEBI:35705"},{"id":"T74529","span":{"begin":39,"end":48},"obj":"UBERON:0002048"},{"id":"T44124","span":{"begin":150,"end":158},"obj":"SP_7"},{"id":"T63961","span":{"begin":170,"end":179},"obj":"UBERON:0002048"},{"id":"T81322","span":{"begin":218,"end":227},"obj":"UBERON:0002048"},{"id":"T51311","span":{"begin":305,"end":316},"obj":"NCBITaxon:1"},{"id":"T81106","span":{"begin":355,"end":365},"obj":"CL:0000775"},{"id":"T17383","span":{"begin":379,"end":385},"obj":"CL:0000084"},{"id":"T96288","span":{"begin":484,"end":501},"obj":"CHEBI:35705;CHEBI:35705"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}

{"project":"2_test","denotations":[{"id":"32572532-25354514-47963394","span":{"begin":511,"end":512},"obj":"25354514"},{"id":"T48775","span":{"begin":511,"end":512},"obj":"25354514"}],"text":"se definitions of influenza-associated pulmonary aspergillosis in order to facilitate clinical studies and the definition may also be useful to study COVID-19-associated pulmonary aspergillosis.\n\nIntroduction\nInvasive pulmonary aspergillosis (IPA) is a well-recognized disease affecting immunocompromised individuals with prolonged neutropenia, inherited neutrophil disorders or T cell defects, with the risk depending on the patients’ underlying disease and the type and duration of immunosuppressive therapy [1]. Patients at the highest risk of invasive asper"}